USD 53.0
(88.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -2.09 Million USD | 64.84% |
2022 | -5.94 Million USD | -172.55% |
2021 | -2.18 Million USD | -5.0% |
2020 | -2.07 Million USD | -157.87% |
2019 | -805.81 Thousand USD | -54942.01% |
2018 | -1464.00 USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -2.14 Million USD | -296.18% |
2024 Q2 | -663.63 Thousand USD | 69.07% |
2023 FY | -2.09 Million USD | 64.84% |
2023 Q4 | -541.63 Thousand USD | 21.1% |
2023 Q2 | -352.14 Thousand USD | 31.17% |
2023 Q1 | -511.6 Thousand USD | -178.79% |
2023 Q3 | -686.46 Thousand USD | -94.94% |
2022 Q1 | -376.65 Thousand USD | 8.07% |
2022 Q4 | -183.51 Thousand USD | 96.13% |
2022 Q3 | -4.73 Million USD | -1212.62% |
2022 FY | -5.94 Million USD | -172.55% |
2022 Q2 | -360.79 Thousand USD | 4.21% |
2021 Q1 | -683.68 Thousand USD | -11.49% |
2021 FY | -2.18 Million USD | -5.0% |
2021 Q4 | -409.73 Thousand USD | 25.64% |
2021 Q3 | -551.02 Thousand USD | 19.4% |
2021 Q2 | -683.68 Thousand USD | 0.0% |
2020 Q2 | -466.83 Thousand USD | -0.0% |
2020 Q4 | -613.19 Thousand USD | -8.13% |
2020 FY | -2.07 Million USD | -157.87% |
2020 Q3 | -567.09 Thousand USD | -21.48% |
2020 Q1 | -466.83 Thousand USD | 0.0% |
2019 FY | -805.81 Thousand USD | -54942.01% |
2018 FY | -1464.00 USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Cell MedX Corp. | -142.48 Thousand USD | -1367.435% |